Hussman Strategic Advisors Inc. Sells 42,000 Shares of Phibro Animal Health Corporation $PAHC

Hussman Strategic Advisors Inc. cut its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 50.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 42,000 shares of the company’s stock after selling 42,000 shares during the quarter. Hussman Strategic Advisors Inc. owned 0.10% of Phibro Animal Health worth $1,699,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of the stock. Geode Capital Management LLC grew its holdings in Phibro Animal Health by 1.4% during the second quarter. Geode Capital Management LLC now owns 554,927 shares of the company’s stock worth $14,175,000 after buying an additional 7,841 shares in the last quarter. Millennium Management LLC grew its stake in shares of Phibro Animal Health by 74.3% in the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock worth $7,733,000 after acquiring an additional 154,281 shares in the last quarter. Ranger Investment Management L.P. raised its holdings in shares of Phibro Animal Health by 101.1% in the second quarter. Ranger Investment Management L.P. now owns 357,970 shares of the company’s stock valued at $9,143,000 after purchasing an additional 179,975 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of Phibro Animal Health by 43.2% in the second quarter. Arrowstreet Capital Limited Partnership now owns 275,066 shares of the company’s stock valued at $7,025,000 after purchasing an additional 83,018 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Phibro Animal Health by 0.3% during the second quarter. Bank of New York Mellon Corp now owns 268,877 shares of the company’s stock valued at $6,867,000 after purchasing an additional 906 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on PAHC. JPMorgan Chase & Co. increased their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday, December 29th. Finally, Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $31.40.

Phibro Animal Health Trading Down 1.8%

NASDAQ:PAHC opened at $38.80 on Thursday. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $46.42. The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32. The firm’s 50 day moving average is $39.92 and its 200 day moving average is $37.69. The stock has a market capitalization of $1.57 billion, a PE ratio of 23.37, a price-to-earnings-growth ratio of 1.12 and a beta of 0.79.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.15. The business had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Sell-side analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Wednesday, November 26th. Phibro Animal Health’s payout ratio is currently 28.92%.

Insider Buying and Selling

In other Phibro Animal Health news, CEO Jack Bendheim sold 1,235 shares of the stock in a transaction dated Friday, January 23rd. The shares were sold at an average price of $40.55, for a total transaction of $50,079.25. Following the completion of the transaction, the chief executive officer owned 15,445 shares in the company, valued at $626,294.75. This trade represents a 7.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders have sold 151,115 shares of company stock worth $6,557,541 over the last quarter. 50.13% of the stock is owned by corporate insiders.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.